The role of fibroblast growth factor-23 in left atrial volume.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  American Heart Journal

• Publication date

  2013-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.ahj.2013.02.022PMID 23622923
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Vitamin D reduces left atrial volume in patients with left ventricular hypertrophy and chronic kidney disease.

  2012cited by this paper
• Fibroblast Growth Factor 23 Predicts Left Ventricular Mass and Induces Cell Adhesion Molecule Formation

  2011cited by this paper
• FGF23 induces left ventricular hypertrophy.

  2011cited by this paper
• Effects of vitamin D replacement therapy on serum FGF23 concentrations in vitamin D-deficient women in short term.

  2010cited by this paper
• Human Fibroblast Growth Factor-23 Mutants Suppress Na+-dependent Phosphate Co-transport Activity and 1α,25-Dihydroxyvitamin D3 Production*

  2003cited by this paper

• The Effect of Six Weeks of Moderate-Intensity Endurance Training on Serum Levels of Klotho and Expression of the Fibroblast-23 Growth Factor Gene (FGF23) in the Hearts of Diabetic Rats: An Experimental Study

  2021cites this paper
• Effect of High Intensity Interval Training on the Level of Atrial Fibrillation, Fibroblast Growth Factor 23 and Klotho Protein in Male Rats with Renal Failure

  2020cites this paper
• FGF-23 and cardiovascular disease: review of literature

  2016cites this paper
• Predictive value of circulating fibroblast growth factor-23 on atrial fibrillation: A meta-analysis.

  2016cites this paper
• Circulating Fibroblast Growth Factor 23 Has a U-Shaped Association With Atrial Fibrillation Prevalence.

  2015cites this paper
• Epidemiological evidence and future perspective in kidney diseases

  2015cites this paper